BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32381396)

  • 1. Synthesis, biochemical evaluation, and molecular modeling of organophosphate-coumarin hybrids as potent and selective butyrylcholinesterase inhibitors.
    Macklin LJ; Schwans JP
    Bioorg Med Chem Lett; 2020 Jul; 30(13):127213. PubMed ID: 32381396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biochemical evaluation, and molecular modeling studies of aryl and arylalkyl di-n-butyl phosphates, effective butyrylcholinesterase inhibitors.
    Nakayama K; Schwans JP; Sorin EJ; Tran T; Gonzalez J; Arteaga E; McCoy S; Alvarado W
    Bioorg Med Chem; 2017 Jun; 25(12):3171-3181. PubMed ID: 28416102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of novel coumarin-pyridinium hybrids: In vitro cholinesterase inhibitory activity.
    Vafadarnejad F; Mahdavi M; Karimpour-Razkenari E; Edraki N; Sameem B; Khanavi M; Saeedi M; Akbarzadeh T
    Bioorg Chem; 2018 Apr; 77():311-319. PubMed ID: 29421707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Series of New Hydrazone Derivatives: Synthesis, Molecular Docking and Anticholinesterase Activity Studies.
    Bozbey İ; Özdemir Z; Uslu H; Özçelik AB; Şenol FS; Orhan İE; Uysal M
    Mini Rev Med Chem; 2020; 20(11):1042-1060. PubMed ID: 31660824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alkynyl and β-ketophosphonates: Selective and potent butyrylcholinesterase inhibitors.
    Cavallaro V; Moglie YF; Murray AP; Radivoy GE
    Bioorg Chem; 2018 Apr; 77():420-428. PubMed ID: 29427857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ionic liquid-enabled synthesis, cholinesterase inhibitory activity, and molecular docking study of highly functionalized tetrasubstituted pyrrolidines.
    Kumar RS; Almansour AI; Arumugam N; Althomili DMQ; Altaf M; Basiri A; D K; Sai Manohar T; S V
    Bioorg Chem; 2018 Apr; 77():263-268. PubMed ID: 29421701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel cinnamic acid-tryptamine hybrids as potent butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study.
    Ghafary S; Najafi Z; Mohammadi-Khanaposhtani M; Nadri H; Edraki N; Ayashi N; Larijani B; Amini M; Mahdavi M
    Arch Pharm (Weinheim); 2018 Oct; 351(10):e1800115. PubMed ID: 30284339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of novel 5-(aroylhydrazinocarbonyl)escitalopram as cholinesterase inhibitors.
    Nisa MU; Munawar MA; Iqbal A; Ahmed A; Ashraf M; Gardener QA; Khan MA
    Eur J Med Chem; 2017 Sep; 138():396-406. PubMed ID: 28688279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of 4-substituted coumarins as novel acetylcholinesterase inhibitors.
    Razavi SF; Khoobi M; Nadri H; Sakhteman A; Moradi A; Emami S; Foroumadi A; Shafiee A
    Eur J Med Chem; 2013 Jun; 64():252-9. PubMed ID: 23644208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase.
    Kilic B; Gulcan HO; Aksakal F; Ercetin T; Oruklu N; Umit Bagriacik E; Dogruer DS
    Bioorg Chem; 2018 Sep; 79():235-249. PubMed ID: 29775949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular-docking-guided design and synthesis of new IAA-tacrine hybrids as multifunctional AChE/BChE inhibitors.
    Cheng ZQ; Zhu KK; Zhang J; Song JL; Muehlmann LA; Jiang CS; Liu CL; Zhang H
    Bioorg Chem; 2019 Mar; 83():277-288. PubMed ID: 30391700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, Synthesis, and Cholinesterase Inhibition Assay of Coumarin-3-carboxamide-N-morpholine Hybrids as New Anti-Alzheimer Agents.
    Tehrani MB; Rezaei Z; Asadi M; Behnammanesh H; Nadri H; Afsharirad F; Moradi A; Larijani B; Mohammadi-Khanaposhtani M; Mahdavi M
    Chem Biodivers; 2019 Jul; 16(7):e1900144. PubMed ID: 31155827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of some new 3-coumaranone and coumarin derivatives as dual inhibitors of acetyl- and butyrylcholinesterase.
    Alipour M; Khoobi M; Nadri H; Sakhteman A; Moradi A; Ghandi M; Foroumadi A; Shafiee A
    Arch Pharm (Weinheim); 2013 Aug; 346(8):577-87. PubMed ID: 23852709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and Synthesis of Novel Arylisoxazole-Chromenone Carboxamides: Investigation of Biological Activities Associated with Alzheimer's Disease.
    Saeedi M; Rastegari A; Hariri R; Mirfazli SS; Mahdavi M; Edraki N; Firuzi O; Akbarzadeh T
    Chem Biodivers; 2020 May; 17(5):e1900746. PubMed ID: 32154628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological evaluation of novel carbamates as potential inhibitors of acetylcholinesterase and butyrylcholinesterase.
    Wu J; Pistolozzi M; Liu S; Tan W
    Bioorg Med Chem; 2020 Mar; 28(5):115324. PubMed ID: 32008882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.
    Mutahir S; Jończyk J; Bajda M; Khan IU; Khan MA; Ullah N; Ashraf M; Qurat-ul-Ain ; Riaz S; Hussain S; Yar M
    Bioorg Chem; 2016 Feb; 64():13-20. PubMed ID: 26595185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient synthesis of novel dialkyl-3-cyanopropylphosphate derivatives and evaluation of their anticholinesterase activity.
    Aouani I; Sellami B; Lahbib K; Cavalier JF; Touil S
    Bioorg Chem; 2017 Jun; 72():301-307. PubMed ID: 28500956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, preliminarily biological evaluation and molecular docking study of new Olaparib analogues as multifunctional PARP-1 and cholinesterase inhibitors.
    Gao CZ; Dong W; Cui ZW; Yuan Q; Hu XM; Wu QM; Han X; Xu Y; Min ZL
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):150-162. PubMed ID: 30427217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel coumarin-3-carboxamides bearing N-benzylpiperidine moiety as potent acetylcholinesterase inhibitors.
    Asadipour A; Alipour M; Jafari M; Khoobi M; Emami S; Nadri H; Sakhteman A; Moradi A; Sheibani V; Homayouni Moghadam F; Shafiee A; Foroumadi A
    Eur J Med Chem; 2013; 70():623-30. PubMed ID: 24211638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of acridone glycosides as selective BChE inhibitors.
    Ma W; Bi J; Zhao C; Gao Y; Zhang G
    Carbohydr Res; 2020 May; 491():107977. PubMed ID: 32169593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.